Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis
NCT02782312
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Bronchiectasis
Interventions
DRUG:
ICS+LABA
OTHER:
routine therapy
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China